助听器在患有轻度至中度单边听力损失的患者的客观和主观疗效:一项前性研究

相关实验视频

Updated: Jul 14, 2025

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

Hantai Kim¹, Oak-Sung Choo², Jungho Ha³

¹Department of Otorhinolaryngology-Head and Neck Surgery, Konyang University College of Medicine, Daejeon, 35365, Republic of Korea.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

|October 6, 2023

概括

单侧助听器可以显著减少单侧感应神经听力损失 (USNHL) 患者的障碍. 在HHIE问卷中,听力障碍得分为20或以上,表明助听器适用于USNHL.

科学领域:

听力学听力学是指听力学.
耳鼻喉科耳鼻喉科耳鼻喉科
康复医学康复医学康复医学

背景情况:

单边感应神经听力损失 (USNHL) 对听力康复提出了独特的挑战.
评估单方面助听器的价值需要评估客观的听觉测量和客观的患者报告的结果.

研究的目的:

确定单边助听器在患有轻度至中度USNHL的患者中的听力学和主观益处.
识别患者的特征和自我报告的残疾水平,从而预测助听器的成功结果.

主要方法:

37名患有轻度至中度USNHL的患者配备了单侧助听器.
客观措施包括功能增益,语音歧视得分 (SDS),听力噪音测试 (HINT) 和声音定位.
主观评估使用了老年人听力障碍清单 (HHIE) 问卷在安装后的1,2,3个月.

主要成果:

听力障碍最显著的减少是在最初HHIE分数高的患者 (显著障碍组) 中观察到的.
在患者组之间没有发现功能增益或辅助SDS的显著差异.
显著障碍组的HINT分数有所改善,复合信号噪声比 (SNR) 降低.
没有辅助的HHIE分数≥20的患者表现出复合SNR显著下降,表明噪音听力有所改善.

结论:

老年人听力障碍清单 (HHIE) 是评估USNHL患者不适的宝贵工具.
一个HHIE总得分为20或以上表明,单侧助听器可能对患有轻度至中度USNHL的患者有益.

关键词:

有效性有效性.助听器是一种助听器.在噪音中听觉.问卷调查问卷问卷调查问卷单边听力损失是一种单边的听力损失.单边感应神经神经听力损失.

更多相关视频

Electrically Evoked Stapedius Reflex Measurements in Cochlear Implantation and Its Application in the Postoperative Fitting Process

Electrically Evoked Stapedius Reflex Measurements in Cochlear Implantation and Its Application in the Postoperative Fitting Process

Published on: June 21, 2024

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages

Published on: March 24, 2023

相关概念视频

Dose-Response Relationship: Potency and Efficacy

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...